Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
*Prunella vulgaris* is a perennial herb in the genus *Prunella*, widely used in Traditional Chinese Medicine (TCM) for its anti-inflammatory, antimicrobial, and immunomodulatory properties. In the context of thyroid health, it is primarily utilized to treat benign thyroid nodules and goiter. The mechanism of action is thought to involve the inhibition of thyroid cell proliferation and the modulation of inflammatory cytokines, potentially through the regulation of the TGF-beta/Smad signaling pathway or antioxidant effects. It is often formulated as tablets (Xiakucao Pian) or oral liquids for clinical use in China, where it is evaluated for its ability to reduce nodule size and improve clinical symptoms in patients with small benign nodules.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on prunella vulgaris.